phosphine has been researched along with Breast Cancer in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, A; Singh, K; Suntharalingam, K; Xiao, Z | 1 |
| Amici, A; Andreani, C; Bartolacci, C; Dou, QP; Ferraro, S; Galassi, R; Gambini, V; Iezzi, M; Maina, EW; Marchini, C; Pucciarelli, S; Ramadori, AT; Simon, OC; Tilio, M; Wang, J; Wu, G | 1 |
| Komarnicka, UK; Kozieł, S; Kyzioł, A; Starosta, R | 1 |
| Cutillas, N; Donaire, A; Janiak, C; Martínez, A; Pedreño, M; Rodríguez, V; Ruiz, J; Yellol, GS; Zamora, A | 1 |
| Cronjé, MJ; Ferreira, E; Meijboom, R; Munyaneza, A; Omondi, B | 1 |
| Chan, AK; Chan, AS; Chan, P; Cheng, CH; Cheng, GY; Chui, CH; Gambari, R; Kan, CW; Kok, SH; Lai, PB; Lam, KH; Lau, FY; Tang, JC; Tang, W; Tong, CS; Wong, RS; Xu, L; Yuen, MC | 1 |
| Berners-Price, SJ; Filipovska, A; Leedman, PJ; Nichols, SJ; Rackham, O | 1 |
7 other study(ies) available for phosphine and Breast Cancer
| Article | Year |
|---|---|
The Discrete Breast Cancer Stem Cell Mammosphere Activity of Group 10-Bis(azadiphosphine) Metal Complexes.
Topics: Antineoplastic Agents; Aza Compounds; Breast Neoplasms; Coordination Complexes; DNA Damage; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Neoplastic Stem Cells; Particle Size; Phosphines; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |
In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancer.
Topics: Antineoplastic Agents; Apoptosis; Azoles; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Organogold Compounds; Phosphines; Structure-Activity Relationship | 2018 |
Selective Cu(I) complex with phosphine-peptide (SarGly) conjugate contra breast cancer: Synthesis, spectroscopic characterization and insight into cytotoxic action.
Topics: A549 Cells; Antineoplastic Agents; Breast Neoplasms; Coordination Complexes; Copper; Female; Humans; MCF-7 Cells; Peptides; Phosphines | 2018 |
Anticancer C,N-cycloplatinated(II) complexes containing fluorinated phosphine ligands: synthesis, structural characterization, and biological activity.
Topics: Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cathepsin B; Cattle; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Female; Halogenation; Humans; Ligands; Models, Molecular; Organoplatinum Compounds; Ovarian Neoplasms; Ovary; Phosphines | 2013 |
The effect of 1:2 Ag(I) thiocyanate complexes in MCF-7 breast cancer cells.
Topics: Breast Neoplasms; Cell Cycle; Cell Death; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; HEK293 Cells; Humans; MCF-7 Cells; Organometallic Compounds; Phosphines; Silver; Structure-Activity Relationship; Thiocyanates | 2015 |
The preparation of 2,6-disubstituted pyridinyl phosphine oxides as novel anti-cancer agents.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Female; Humans; Liver Neoplasms; Male; Middle Aged; Oxides; Phosphines | 2009 |
A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: implications for anticancer therapeutics targeted to mitochondria.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Humans; Mitochondria; Molecular Structure; Organogold Compounds; Phosphines; Time Factors | 2007 |